Oral Cell DNA Adducts in Smokers
NCT03285893 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 281
Last updated 2024-11-12
Summary
DNA adducts in the oral mucosa cells of 100 smokers from 3 ethnic groups - Native Hawaiians, Whites, and Japanese Americans with differing risks for lung cancer upon cigarette smoking will be quantified. DNA adducts of tobacco smoke carcinogens will be quantified using both targeted and untargeted approaches.
Conditions
Interventions
- OTHER
-
oral cell DNA adducts
oral cells will be collected, DNA isolated, and analyzed for adducts
Sponsors & Collaborators
-
University of Hawaii
collaborator OTHER - lead OTHER
Principal Investigators
-
Stepehn Hecht, PhD · University of Minnesota
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-01
- Primary Completion
- 2021-08-01
- Completion
- 2021-08-01
Countries
- United States
Study Locations
More Related Trials
-
Validation of DNA Methylation Biomarkers for Oral Cancer Detection
NCT01945697 ·Status: COMPLETED
-
Impact of a Gene Test for Susceptibility to Lung Cancer in Smokers
NCT01176383 ·Status: COMPLETED ·Phase: NA
-
Validation of a Multi-gene Test for Lung Cancer Risk
NCT01130285 ·Status: ACTIVE_NOT_RECRUITING
-
DNA Repair and Genetic Susceptibility to Lung Cancer
NCT00611598 ·Status: COMPLETED
-
DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer
NCT00339859 ·Status: COMPLETED
-
Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker
NCT00318604 ·Status: UNKNOWN
-
Metabolism of NNK Among African Americans
NCT01158456 ·Status: COMPLETED
-
Genetic Susceptibility to Bladder Cancer
NCT00848289 ·Status: ACTIVE_NOT_RECRUITING
-
Genetic Susceptibility to Lung Cancer in Never Smokers
NCT00597636 ·Status: ACTIVE_NOT_RECRUITING
-
Microbiome in Lung Cancer and Other Malignancies
NCT03688347 ·Status: COMPLETED
-
Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
NCT00568906 ·Status: TERMINATED
-
Biological Specimen Collection for Laboratory Methods Development and Training Purposes
NCT00025831 ·Status: COMPLETED
-
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
NCT05366881 ·Status: RECRUITING
-
Cell-free DNA in Hereditary And High-Risk Malignancies 1
NCT04261972 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
NCT06482073 ·Status: RECRUITING
-
Liquid Biopsy in Head and Neck Cancer
NCT03926468 ·Status: UNKNOWN
-
Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871
NCT01015963 ·Status: COMPLETED
-
Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
NCT00213798 ·Status: COMPLETED ·Phase: NA
-
Circulating DNA in Surgically Treated NSCLC
NCT04037150 ·Status: UNKNOWN
-
Skin Cancer Screening Education Study
NCT02352428 ·Status: UNKNOWN ·Phase: NA
-
Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes
NCT00745160 ·Status: COMPLETED
-
Family History Study on Cancer Risk
NCT04145388 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
NCT01653613 ·Status: UNKNOWN
-
S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia
NCT01434329 ·Status: COMPLETED
-
Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage
NCT01143519 ·Status: COMPLETED